These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 22950456)

  • 1. Validity of self-reported use of sulphadoxine-pyrimethamine intermittent presumptive treatment during pregnancy (IPTp): a cross-sectional study.
    Namusoke F; Ntale M; Wahlgren M; Kironde F; Mirembe F
    Malar J; 2012 Sep; 11():310. PubMed ID: 22950456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coverage and efficacy of intermittent preventive treatment with sulphadoxine pyrimethamine against malaria in pregnancy in Côte d'Ivoire five years after its implementation.
    Toure OA; Kone PL; Coulibaly MA; Ako BA; Gbessi EA; Coulibaly B; N' Guessan LT; Koffi D; Beourou S; Soumahoro A; Bassinka I; Nogbou M; Swa T; Gba B; Esmel B; Bokossa EM
    Parasit Vectors; 2014 Nov; 7():495. PubMed ID: 25410760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uptake of intermittent preventive treatment with sulphadoxine-pyrimethamine for malaria during pregnancy and pregnancy outcomes: a cross-sectional study in Geita district, North-Western Tanzania.
    Mpogoro FJ; Matovelo D; Dosani A; Ngallaba S; Mugono M; Mazigo HD
    Malar J; 2014 Nov; 13():455. PubMed ID: 25421496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of a community-based delivery of intermittent preventive treatment of malaria in pregnancy on treatment seeking for malaria at health units in Uganda.
    Mbonye AK; Schultz Hansen K; Bygbjerg IC; Magnussen P
    Public Health; 2008 May; 122(5):516-25. PubMed ID: 18358506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perceptions of intermittent preventive treatment of malaria in pregnancy (IPTp) and barriers to adherence in Nasarawa and Cross River States in Nigeria.
    Diala CC; Pennas T; Marin C; Belay KA
    Malar J; 2013 Sep; 12():342. PubMed ID: 24059757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A community effectiveness trial of strategies promoting intermittent preventive treatment with sulphadoxine-pyrimethamine in pregnant women in rural Burkina Faso.
    Gies S; Coulibaly SO; Ouattara FT; Ky C; Brabin BJ; D'Alessandro U
    Malar J; 2008 Sep; 7():180. PubMed ID: 18801158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scaling-up the use of sulfadoxine-pyrimethamine for the preventive treatment of malaria in pregnancy: results and lessons on scalability, costs and programme impact from three local government areas in Sokoto State, Nigeria.
    Orobaton N; Austin AM; Abegunde D; Ibrahim M; Mohammed Z; Abdul-Azeez J; Ganiyu H; Nanbol Z; Fapohunda B; Beal K
    Malar J; 2016 Nov; 15(1):533. PubMed ID: 27814763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of the usage and effectiveness of intermittent preventive treatment and insecticide-treated nets on the indicators of malaria among pregnant women attending antenatal care in the Buea Health District, Cameroon.
    Fokam EB; Ngimuh L; Anchang-Kimbi JK; Wanji S
    Malar J; 2016 Mar; 15():172. PubMed ID: 26987387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of intermittent preventive treatment of malaria against group B Streptococcus colonization in pregnant women: a nested analysis of a randomized controlled clinical trial of sulfadoxine/pyrimethamine versus mefloquine.
    Capan-Melser M; Mombo Ngoma G; Akerey-Diop D; Basra A; Würbel H; Groger M; Mackanga JR; Zoleko-Manego R; Schipulle U; Schwing J; Lötsch F; Rehman K; Matsiegui PB; Agnandji ST; Adegnika AA; Bélard S; González R; Kremsner PG; Menendez C; Ramharter M
    J Antimicrob Chemother; 2015; 70(6):1898-902. PubMed ID: 25722300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of sulfadoxine-pyrimethamine doses for prevention of malaria during pregnancy in hypoendemic area in Tanzania.
    Mikomangwa WP; Minzi O; Mutagonda R; Baraka V; Mlugu EM; Aklillu E; Kamuhabwa AAR
    Malar J; 2020 Apr; 19(1):160. PubMed ID: 32306955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The challenge of using intermittent preventive therapy with sulfadoxine/pyrimethamine among pregnant women in Uganda.
    Wanzira H; Katamba H; Okullo AE; Rubahika D
    Malar J; 2016 Aug; 15(1):401. PubMed ID: 27506609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uptake of intermittent preventive treatment for malaria during pregnancy with Sulphadoxine-Pyrimethamine (IPTp-SP) among postpartum women in Zomba District, Malawi: a cross-sectional study.
    Azizi SC; Chongwe G; Chipukuma H; Jacobs C; Zgambo J; Michelo C
    BMC Pregnancy Childbirth; 2018 Apr; 18(1):108. PubMed ID: 29678150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlates of uptake of optimal doses of sulfadoxine-pyrimethamine for prevention of malaria during pregnancy in East-Central Uganda.
    Martin MK; Venantius KB; Patricia N; Bernard K; Keith B; Allen K; Godfrey A; Rogers T; Damazo KT; Dathan BM
    Malar J; 2020 Apr; 19(1):153. PubMed ID: 32295601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intermittent treatment to prevent pregnancy malaria does not confer benefit in an area of widespread drug resistance.
    Harrington WE; Mutabingwa TK; Kabyemela E; Fried M; Duffy PE
    Clin Infect Dis; 2011 Aug; 53(3):224-30. PubMed ID: 21765070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Socio-demographic and regional disparities in utilization of intermittent preventive treatment for malaria in pregnancy - Nigeria demographic health survey 2013.
    Olugbade OT; Ilesanmi OS; Gubio AB; Ajayi I; Nguku PM; Ajumobi O
    Pan Afr Med J; 2019; 32(Suppl 1):13. PubMed ID: 30949287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors associated with the uptake of intermittent preventive treatment of malaria in pregnancy in the Bamenda health districts, Cameroon.
    Diengou NH; Cumber SN; Nkfusai CN; Mbinyui MS; Viyoff VZ; Bede F; Akwah L; Tsoka-Gwegweni JM; Judith AK
    Pan Afr Med J; 2020; 35():42. PubMed ID: 32499857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intermittent use of sulphadoxine-pyrimethamine for malaria prevention: a cross-sectional study of knowledge and practices among Ugandan women attending an urban antenatal clinic.
    Odongo CO; Bisaso RK; Byamugisha J; Obua C
    Malar J; 2014 Oct; 13():399. PubMed ID: 25306431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and toxicity of sulfadoxine/pyrimethamine: implications for malaria prevention in pregnancy using intermittent preventive treatment.
    Peters PJ; Thigpen MC; Parise ME; Newman RD
    Drug Saf; 2007; 30(6):481-501. PubMed ID: 17536875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of sulphadoxine-pyrimethamine for intermittent preventive treatment of malaria in pregnancy: a retrospective birth outcomes study in Mansa, Zambia.
    Mace KE; Chalwe V; Katalenich BL; Nambozi M; Mubikayi L; Mulele CK; Wiegand RE; Filler SJ; Kamuliwo M; Craig AS; Tan KR
    Malar J; 2015 Feb; 14():69. PubMed ID: 25890159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular markers of resistance to sulphadoxine-pyrimethamine during intermittent preventive treatment of pregnant women in Benin.
    Bertin G; Briand V; Bonaventure D; Carrieu A; Massougbodji A; Cot M; Deloron P
    Malar J; 2011 Jul; 10():196. PubMed ID: 21767415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.